Valuation : West Pharmaceutical Services, Inc.

Market Cap 23.77B 20.44B 19.23B 17.55B 32.74B 2,253B 32.91B 228B 88.14B 1,152B 89.26B 87.31B 3,665B P/E 2026 *
39.4x
P/E 2027 * 34.2x
Enterprise Value 23.27B 20B 18.82B 17.17B 32.05B 2,206B 32.22B 223B 86.27B 1,127B 87.37B 85.46B 3,588B EV / Sales 2026 *
6.89x
EV / Sales 2027 * 6.34x
Free-Float
92.89%
Yield 2026 *
0.27%
Yield 2027 * 0.29%
Manager TitleAgeSince
Chief Executive Officer 52 2026-08-30
Director of Finance/CFO 57 2025-08-03
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 65 2011-01-31
Director/Board Member 69 2011-03-06
Director/Board Member 56 2012-02-11
Change 5-day change 1-year change 3-year change Capi.($)
-15.34%-5.12% - - 23.77B
-2.59%-3.13%-20.18%+4.76% 183B
-1.89%+0.38%-0.65%+15.55% 118B
-1.89%-1.90%+9.01%+82.72% 61.96B
-0.49%-4.95%+12.81%+44.34% 50.6B
-3.05%-4.29%-6.51%-32.86% 48.78B
-3.83%-6.22%+8.37%-18.99% 31.9B
-5.19%-1.20% - - 30.44B
-0.65%-0.27%+33.42%-14.09% 23.77B
-2.51%-8.14%-13.24%+5.88% 22.26B
Average -1.64%-2.73%+2.88%+10.91% 63.39B
Weighted average by Cap. -0.80%-1.89%-3.90%+14.19%

Financials

2026 *2027 *
Net sales 3.37B 2.9B 2.73B 2.49B 4.65B 320B 4.67B 32.34B 12.51B 164B 12.67B 12.4B 520B 3.59B 3.08B 2.9B 2.65B 4.94B 340B 4.97B 34.38B 13.3B 174B 13.47B 13.18B 553B
Net income 615M 528M 497M 454M 847M 58.26B 851M 5.89B 2.28B 29.78B 2.31B 2.26B 94.76B 701M 603M 567M 518M 966M 66.48B 971M 6.72B 2.6B 33.98B 2.63B 2.58B 108B
Net Debt -503M -433M -407M -372M -693M -47.71B -697M -4.82B -1.87B -24.39B -1.89B -1.85B -77.6B -1.04B -893M -841M -767M -1.43B -98.51B -1.44B -9.96B -3.85B -50.35B -3.9B -3.82B -160B
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and administration of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by group of products as follows: - proprietary products (81.1%); - contract-manufactured products (18.9%). At the end of 2025, the group had 25 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (43.2%), Germany (12.4%), Ireland (10.8%), France (7.4%), Europe (14.7%) and other (11.5%).
Employees
10,800
Trader
Investor
Global
Quality
ESG MSCI
AAA
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!